November 2017

New Product - Antizol

Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyses the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyses the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. Metabolic acidosis and renal damage are seen with ethylene glycol toxicosis. Metabolic acidosis and visual disturbances (e.g. decreased visual activity and potential blindness) are associated with methanol poisoning. Antizol is indicated for the treatment of ethylene glycol or methanol poisoning. Antizol solution for intravenous infusion (fomepizole 1.5 g/1.5 mL) is supplied in a pack of 4 vials.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au